Evaluating chronic kidney disease in rural South Africa: comparing estimated glomerular filtration rate using point-of-care creatinine to iohexol measured GFR
- PMID: 33711217
- DOI: 10.1515/cclm-2020-1882
Evaluating chronic kidney disease in rural South Africa: comparing estimated glomerular filtration rate using point-of-care creatinine to iohexol measured GFR
Abstract
Objectives: The prevalence of chronic kidney disease is rising rapidly in low- and middle-income countries. Serum creatinine and estimation of glomerular filtration rate (GFR) are critical diagnostic tools, yet access to centralised laboratory services remains limited in primary care resource-limited settings. The aim of this study was to evaluate point-of-care (POC) technologies for serum creatinine measurement and to compare their performance to a gold standard measurement using iohexol measured GFR (mGFR).
Methods: POC creatinine was measured using iSTAT® and StatSensor® devices in capillary and venous whole blood, and laboratory creatinine was measured using the compensated kinetic Jaffe method in 670 participants from a rural area in South Africa. GFR estimating equations Chronic Kidney Disease Epidemiology Collaboration and Modification of Diet in Renal Disease (CKD-EPI and MDRD) for POC and laboratory creatinine were compared to iohexol mGFR.
Results: Calculated GFR for laboratory and POC creatinine measurements overestimated GFR (positive bias of 1.9-34.1 mL/min/1.73 m2). However, all POC devices had less positive bias than the laboratory Jaffe method (1.9-14.7 vs. 34.1 for MDRD, and 8.4-19.9 vs. 28.6 for CKD-EPI). Accuracy within 30% of mGFR ranged from 0.56 to 0.72 for POC devices and from 0.36 to 0.43 for the laboratory Jaffe method. POC devices showed wider imprecision with coefficients of variation ranging from 4.6 to 10.2% compared to 3.5% for the laboratory Jaffe method.
Conclusions: POC estimated GFR (eGFR) showed improved performance over laboratory Jaffe eGFR, however POC devices suffered from imprecision and large bias. The laboratory Jaffe method performed poorly, highlighting the need for laboratories to move to enzymatic methods to measure creatinine.
Keywords: chronic kidney disease; creatinine; eGFR; iohexol mGFR; low- and middle-income countries (LMICs); point-of-care.
© 2021 Sean Currin et al., published by De Gruyter, Berlin/Boston.
References
-
- George, JA, Brandenburg, J-T, Fabian, J, Crowther, NJ, Agongo, G, Alberts, M, et al.. Kidney damage and associated risk factors in rural and urban sub-Saharan Africa (AWI-Gen): a cross-sectional population study. Lancet Glob Health 2019;7:e1632–43. https://doi.org/10.1016/s2214-109x(19)30443-7.
-
- Stanifer, JW, Muiru, A, Jafar, TH, Patel, UD. Chronic kidney disease in low- and middle-income countries. Nephrol Dial Transplant 2016;31:868–74. https://doi.org/10.1093/ndt/gfv466.
-
- KDIGO Working Group. Kidney disease: improving global outcomes (KDIGO). KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013;3:1–150.
-
- Levey, AS, Inker, LA. GFR as the “gold standard”: estimated, measured, and true. Am J Kidney Dis 2016;67:9–12. https://doi.org/10.1053/j.ajkd.2015.09.014.
-
- Miller, WG, Jones, GRD. Estimated glomerular filtration rate; laboratory implementation and current global status. Adv Chron Kidney Dis 2018;25:7–13. https://doi.org/10.1053/j.ackd.2017.09.013.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous